Sentences with phrase «presenting clinical findings»

Dealing with patient data and presenting clinical findings to clinicians, healthcare workers and patients.

Not exact matches

This is an incredibly difficult question to answer for a variety of reasons, most importantly because over the years our once vaunted «beautiful» style of play has become a shadow of it's former self, only to be replaced by a less than stellar «plug and play» mentality where players play out of position and adjustments / substitutions are rarely forthcoming before the 75th minute... if you look at our current players, very few would make sense in the traditional Wengerian system... at present, we don't have the personnel to move the ball quickly from deep - lying position, efficient one touch midfielders that can make the necessary through balls or the disciplined and pacey forwards to stretch defences into wide positions, without the aid of the backs coming up into the final 3rd, so that we can attack the defensive lanes in the same clinical fashion we did years ago... on this current squad, we have only 1 central defender on staf, Mustafi, who seems to have any prowess in the offensive zone or who can even pass two zones through so that we can advance play quickly out of our own end (I have seen some inklings that suggest Holding might have some offensive qualities but too early to tell)... unfortunately Mustafi has a tendency to get himself in trouble when he gets overly aggressive on the ball... from our backs out wide, we've seen pace from the likes of Bellerin and Gibbs and the spirited albeit offensively stunted play of Monreal, but none of these players possess the skill - set required in the offensive zone for the new Wenger scheme which requires deft touches, timely runs to the baseline and consistent crossing, especially when Giroud was playing and his ratio of scored goals per clear chances was relatively low (better last year though)... obviously I like Bellerin's future prospects, as you can't teach pace, but I do worry that he regressed last season, which was obvious to Wenger because there was no way he would have used Ox as the right side wing - back so often knowing that Barcelona could come calling in the off - season, if he thought otherwise... as for our midfielders, not a single one, minus the more confident Xhaka I watched played for the Swiss national team a couple years ago, who truly makes sense under the traditional Wenger model... Ramsey holds onto the ball too long, gives the ball away cheaply far too often and abandons his defensive responsibilities on a regular basis (doesn't score enough recently to justify): that being said, I've always thought he does possess a little something special, unfortunately he thinks so too... Xhaka is a little too slow to ever boss the midfield and he tends to telegraph his one true strength, his long ball play: although I must admit he did get a bit better during some points in the latter part of last season... it always made me wonder why whenever he played with Coq Wenger always seemed to play Francis in a more advanced role on the pitch... as for Coq, he is way too reckless at the wrong times and has exhibited little offensive prowess yet finds himself in and around the box far too often... let's face it Wenger was ready to throw him in the trash heap when injuries forced him to use Francis and then he had the nerve to act like this was all part of a bigger Wenger constructed plan... he like Ramsey, Xhaka and Elneny don't offer the skills necessary to satisfy the quick transitory nature of our old offensive scheme or the stout defensive mindset needed to protect the defensive zone so that our offensive players can remain aggressive in the final third... on the front end, we have Ozil, a player of immense skill but stunted by his physical demeanor that tends to offend, the fact that he's been played out of position far too many times since arriving and that the players in front of him, minus Sanchez, make little to no sense considering what he has to offer (especially Giroud); just think about the quick counter-attack offence in Real or the space and protection he receives in the German National team's midfield, where teams couldn't afford to focus too heavily on one individual... this player was a passing «specialist» long before he arrived in North London, so only an arrogant or ignorant individual would try to reinvent the wheel and / or not surround such a talent with the necessary components... in regards to Ox, Walcott and Welbeck, although they all possess serious talents I see them in large part as headless chickens who are on the injury table too much, lack the necessary first - touch and / or lack the finishing flair to warrant their inclusion in a regular starting eleven; I would say that, of the 3, Ox showed the most upside once we went to a back 3, but even he became a bit too consumed by his pending contract talks before the season ended and that concerned me a bit... if I had to choose one of those 3 players to stay on it would be Ox due to his potential as a plausible alternative to Bellerin in that wing - back position should we continue to use that formation... in Sanchez, we get one of the most committed skill players we've seen on this squad for some years but that could all change soon, if it hasn't already of course... strangely enough, even he doesn't make sense given the constructs of the original Wenger offensive model because he holds onto the ball too long and he will give the ball up a little too often in the offensive zone... a fact that is largely forgotten due to his infectious energy and the fact that the numbers he has achieved seem to justify the means... finally, and in many ways most crucially, Giroud, there is nothing about this team or the offensive system that Wenger has traditionally employed that would even suggest such a player would make sense as a starter... too slow, too inefficient and way too easily dispossessed... once again, I think he has some special skills and, at times, has showed some world - class qualities but he's lack of mobility is an albatross around the necks of our offence... so when you ask who would be our best starting 11, I don't have a clue because of the 5 or 6 players that truly deserve a place in this side, 1 just arrived, 3 aren't under contract beyond 2018 and the other was just sold to Juve... man, this is theraputic because following this team is like an addiction to heroin without the benefits

* While there are, as of yet, no clinical studies to confirm the results, a laboratory study conducted at the College of Pharmacy at Oregon State University (OSU) presented at a December 2007 meeting of the American Society of Health - System Pharmacists found that an ointment containing benzethonium chloride with tea tree and white thyme oil worked best against all four tested MRSA strains, while ointments containing neomycin, polymyxin, and gramicidin also had some antibacterial effectiveness.

Labadorf believes that at present, these findings are too preliminary to suggest new clinical treatments.

The findings of the experimental study, presented in the most recent issue of the American Journal of Clinical Nutrition, suggest that improving maternal DHA nutrition has a favorable programming effect on the fetus that influences body composition in early childhood.

At the 2015 AACC Annual Meeting & Clinical Lab Expo, researchers will present findings that a first - of - its - kind smartphone test for chlamydia can detect the disease with high accuracy, which could reduce the prevalence of this sexually transmitted disease (STD) by making chlamydia screening easier and cheaper.

Findings were presented at the WCLC are based on the updated results of 12 lung cancer patients enrolled in the clinical trial with pembro and irinotecan or gemcitabine with or without vinorelbine or docetaxel.

The evidence presented further suggests that IL - 17 is necessary only for the initial sensitization to allergen and may therefore explain the recent finding that an IL - 17RA antibody was unable to affect established asthma symptoms in a recent clinical trial.»

The findings will be presented at the American Society of Clinical Oncology (ASCO) 52nd Annual Meeting in Chicago.

But according to new findings presented at the American College of Surgeons Clinical Congress 2017, a bariatric surgical procedure, and the weight loss that follows it, actually allows the heart to return to its natural shape and function.

Hawley will present the findings Nov. 30 at the American Society of Clinical Oncology's Quality Care Symposium.

A simplified frailty index created by surgeons at Wayne State University School of Medicine in Detroit, Mich., is a reliable tool for assessing risk of mortality and serious complications in older patients considering total hip and knee replacement procedures, according to new study findings presented at the 2014 Clinical Congress of the American College of Surgeons.

As time lapses, many colonoscopy patients become less and less likely to recall when and where they last had the procedure performed; who the doctor was who performed it; whether polyps were found, and, if so, the number and size of those polyps, according to new study results presented at the 2015 Clinical Congress of the American College of Surgeons.

The first - of - its - kind study found the dual treatments to be safe and elicit a clinical response in patients, according to new results from a phase I trial to be presented at the AACR Annual Meeting 2015 on April 19.

They will present their findings in an oral presentation June 1 at the annual meeting of the American Society of Clinical Oncology in Chicago.

A comprehensive analysis of the study's results — published in June 1 online edition of the New England Journal of Medicine and to be presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago — found participants treated with enzalutamide saw an 81 percent reduction in the risk the cancer would progress and a 29 percent reduction in the risk of death.

Sylvia Adams, MD, associate professor of medical oncology at Perlmutter Cancer Center and principal investigator of this study, presented the findings on June 3 in Chicago at the annual meeting of the American Society of Clinical Oncology.

In a preliminary finding (abstract 5568) presented Monday, June 6, at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago, researchers revealed they have found bacteria in the ovaries and in the fallopian tubes.

The OSUCCC — James team presented their findings at the American Association of Clinical Oncology (ASCO) annual meeting in Chicago.

The findings were published this month in the Journal of Clinical Oncology and will be presented Oct. 19 at the 2015 Annual Meeting of the American Society for Radiation Oncology.

They say their findings, being presented June 2 at the 50th annual meeting of the American Society of Clinical Oncology (ASCO), offered several clinical insights that could lead to different treatment strategies and perhaps influence staging of advanced mClinical Oncology (ASCO), offered several clinical insights that could lead to different treatment strategies and perhaps influence staging of advanced mclinical insights that could lead to different treatment strategies and perhaps influence staging of advanced melanoma.

That theory was tested in a study of heart attack survivors led by the Duke Clinical Research Institute; findings were presented March 11 at the American College of Cardiology annual scientific sessions meeting in Orlando.

Patients with bladder cancer are two times more likely to have complications after a radical cystectomy procedure if they have a biomarker for poor nutritional status before the operation, according to study findings presented today at the 2013 Clinical Congress of the American College of Surgeons.

The team's findings will be presented at the American Society of Clinical Oncology (ASCO) 52nd Annual Meeting in Chicago.

However, according to new research findings presented at the 2013 Clinical Congress of the American College of Surgeons, same - hospital readmission rates are an unreliable surrogate for predicting all - hospital readmissions rates.

Those findings are among results of six studies of investigational chimeric antigen receptor (CAR) T cells for both adult and pediatric leukemias, adult lymphomas, and ovarian cancer which will be presented during the 2016 American Society of Clinical Oncology Annual Meeting.

The findings were published today in The New England Journal of Medicine and presented as Late - Breaking Clinical Trial at the American College of Cardiology's 67th Annual Scientific Session and Expo in Orlando.

Each chart was reviewed for patient demographics, presenting symptoms and signs, tumor location and size, imaging findings, extent of surgical resection, histopathological findings, radiographic follow - up, tumor recurrence, and clinical outcome.

The course will provide insight into the past, present and future of precision bioinformatics, with particular emphasis on clinical finding of variants.

Based on our findings, the occurrence of cancer is much higher in adults over 75 years of age compared with the proportion of patients in this age group who enroll in clinical trials,» said lead study author Bindu Kanapuru, MD, medical officer in the Division of Hematology Products, Office of Hematology and Oncology Products in the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, who presented the results at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9 — 12 in Atlanta.

Preliminary findings presented at ASH suggest a «favorable emerging clinical profile» for once weekly administration of MLN9708 in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.

Mar 30, 2009 Charis Eng, MD, PhD delivered two invited lectures at the Annual Meeting of the American College of Medical Genetics, March 25, 2009 Charis Eng, MD, PhD, the Sondra J. and Stephen R. Hardis Chair of Cancer Genomic Medicine and founding Chairwoman of the Genomic Medicine Institute, and Director of the Center for Personalized Genetic Healthcare within the GMI, presented the opening lecture on «Heritable Breast and Colon Cancer Syndromes: Not Just the Usual Suspects» at the College's Educational Workshop to update the audience of the very broad genetic differential diagnosis of breast cancer as well as colon cancer, their clinical and molecular diagnosis, risk assessment, and medical management.

Scientists and vaccine developers involved in EVI projects presented project progress and research findings, highlighting one of the most important areas of EVI's activities; translation of research on diseases of poverty vaccines, focusing on early stages from preclinical to clinical development through harmonisation.

We carried out a sustained advocacy and engagement plan, discussing and / or presenting our findings at numerous events including: the National Information Board Ethics Advisory Committee of the 100,000 Genomes Project, Human Variome Project biennial meeting, the joint congress of the European Society of Human Genetics and European Meeting on Psychosocial Aspects of Genetics, Curating the Clinical Genome and Association for Clinical Genetic Science annual conference

They noted that the present findings warrant a confirmatory clinical trial for SMA rTMS on PD, undertaken on a larger scale.

Sharon Sha presented findings Nov. 4 from a small clinical trial that found administering blood plasma from young donors to people with mild to moderate Alzheimer's disease was safe.

These findings were presented at the June 2017 annual meeting of the American Society of Clinical Oncology.

To report the clinical, neuropsychological, linguistic, imaging, and neuropathological features of a unique case of sporadic Jakob - Creutzfeldt disease in which the patient presented with a logopenic variant of primary progressive aphasia.Case report.Large referral center for atypical memory and aging disorders, particularly Jakob - Creutzfeldt disease.Patient presenting with logopenic variant primary progressive aphasia initially thought to be due to Alzheimer disease.Despite the long, slow 3.5 - year course, the patient was shown to have pathology - proven sporadic Jakob - Creutzfeldt disease.These findings expand the differential of primary progressive aphasia to include prion disease.

In the appropriate clinical setting, suspicion for acute aortic dissection should be raised when patients present with findings that have a high specificity and high positive likelihood ratio (hypotension, pulse deficit,...

The first - of - its - kind study found the dual treatments to be safe and elicit a clinical response in patients, according to new results from a phase I trial to be presented at the AACR Annual Meeting 2015 on Sunday, April 19 (Abstract #CT137).

Both the ovarian and prostate cancer trials could change clinical practice, with more women taking the drug bevacizumab (Avastin) to combat the disease in its advanced stages and more men getting radiation therapy for locally advanced prostate cancer, according to researchers who presented the findings Sunday at the American Society of Clinical Oncology (ASCO) annual meeting in clinical practice, with more women taking the drug bevacizumab (Avastin) to combat the disease in its advanced stages and more men getting radiation therapy for locally advanced prostate cancer, according to researchers who presented the findings Sunday at the American Society of Clinical Oncology (ASCO) annual meeting in Clinical Oncology (ASCO) annual meeting in Chicago.

He and his colleagues are scheduled to present their findings Jan. 20 in San Francisco at the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium.

Thus, if any inflammation is present, which is found in numerous clinical and subclinical conditions (as above), the body will have lower cellular T3 levels that are often inadequate for optimal functioning; but the pituitary will have increased levels of T3, resulting in a lowering of the TSH that would potentially be inappropriately interpreted as an indication of «normal» thyroid levels.

One clinical study presented findings that people with low levels of the active form of vitamin D had reduced neuroprotection and loss of brain development.

«The present findings support recent clinical trials suggesting that regular intake of cocoa flavanols may have a beneficial effect on cognitive function, and possibly protect against normal age - related cognitive decline.»

Here we present evidence from clinical and basic research, including positive and negative findings from our laboratory, identifying ketogenic diets as a platform deserving further optimization and exploration.

Diabetes mellitus is diagnosed when clinical signs are present along with laboratory findings of DM.

«Finding genes for complex traits: mostly agony and little ecstasy,» presented by Dr. Rory Todhunter, BVSc, PhD, Greenberg Professor of Surgery, Cornell University Department of Clinical Sciences

The findings, presented at the annual meeting of the American College of Gastroenterology in San Diego, Calif., are not only important because a large group (2,430) of patients participated, but they resulted from the only study to date that has compared these two methods in a general clinical practice setting, among all the patients who needed a colonoscopy and with all the physicians who performed it.

Usual duties listed on a Clinical Documentation Specialist example resume are collecting data, writing reports, identifying health care issues, updating databases, finding areas that can be improved, and presenting findings to medical staff.